Monteiro C, Toth B, Brunstein F, Bobbala A, et al. A Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants with Mild-to-Moderate Alzheimer's Disease (Lauriet). Neurology 2023 Aug 29:10.1212/WNL.0000000000207663.
PMID: 37643887